UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 90 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | – | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 48 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 48 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 48 | -59.3% | 0.00% | – |
| Q3 2020 | $2,000 | -93.8% | 118 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $32,000 | +1500.0% | 118 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 118 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 118 | -11.3% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 133 | -11.3% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 150 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |